These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 16525649)
21. Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells. Rashid-Kolvear F; Taboski MA; Nguyen J; Wang DY; Harrington LA; Done SJ BMC Cancer; 2010 Jul; 10():390. PubMed ID: 20650001 [TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation. Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168 [TBL] [Abstract][Full Text] [Related]
23. The human semaphorin 6B gene is down regulated by PPARs. Collet P; Domenjoud L; Devignes MD; Murad H; Schohn H; Dauça M Genomics; 2004 Jun; 83(6):1141-50. PubMed ID: 15177567 [TBL] [Abstract][Full Text] [Related]
24. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands. Crowe DL; Chandraratna RA Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936 [TBL] [Abstract][Full Text] [Related]
25. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages. Cabrero A; Cubero M; Llaverías G; Jové M; Planavila A; Alegret M; Sánchez R; Laguna JC; Carrera MV Metabolism; 2003 May; 52(5):652-7. PubMed ID: 12759900 [TBL] [Abstract][Full Text] [Related]
26. Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Krönke G; Kadl A; Ikonomu E; Blüml S; Fürnkranz A; Sarembock IJ; Bochkov VN; Exner M; Binder BR; Leitinger N Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1276-82. PubMed ID: 17413033 [TBL] [Abstract][Full Text] [Related]
27. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells. Motomura W; Okumura T; Takahashi N; Obara T; Kohgo Y Cancer Res; 2000 Oct; 60(19):5558-64. PubMed ID: 11034103 [TBL] [Abstract][Full Text] [Related]
28. Effects of retinoids and thiazolidinediones on proliferation, insulin release, insulin mRNA, GLUT 2 transporter protein and mRNA of INS-1 cells. Blumentrath J; Neye H; Verspohl EJ Cell Biochem Funct; 2001 Sep; 19(3):159-69. PubMed ID: 11494305 [TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle. Cha BS; Ciaraldi TP; Carter L; Nikoulina SE; Mudaliar S; Mukherjee R; Paterniti JR; Henry RR Diabetologia; 2001 Apr; 44(4):444-52. PubMed ID: 11357475 [TBL] [Abstract][Full Text] [Related]
30. 9-cis retinoic acid induces monocyte chemoattractant protein-1 secretion in human monocytic THP-1 cells. Zhu L; Bisgaier CL; Aviram M; Newton RS Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2105-11. PubMed ID: 10479651 [TBL] [Abstract][Full Text] [Related]
31. Additive inhibitory effect of experimentally induced hepatic cirrhosis by agonists of peroxisome proliferator activator receptor gamma and retinoic acid receptor. Bruck R; Weiss S; Aeed H; Pines M; Halpern Z; Zvibel I Dig Dis Sci; 2009 Feb; 54(2):292-9. PubMed ID: 18594976 [TBL] [Abstract][Full Text] [Related]
32. Growth inhibition through activation of peroxisome proliferator-activated receptor gamma in human oesophageal squamous cell carcinoma. Hashimoto Y; Shimada Y; Itami A; Ito T; Kawamura J; Kawabe A; Kaganoi J; Maeda M; Watanabe G; Imamura M Eur J Cancer; 2003 Oct; 39(15):2239-46. PubMed ID: 14522385 [TBL] [Abstract][Full Text] [Related]
33. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma. He BC; Chen L; Zuo GW; Zhang W; Bi Y; Huang J; Wang Y; Jiang W; Luo Q; Shi Q; Zhang BQ; Liu B; Lei X; Luo J; Luo X; Wagner ER; Kim SH; He CJ; Hu Y; Shen J; Zhou Q; Rastegar F; Deng ZL; Luu HH; He TC; Haydon RC Clin Cancer Res; 2010 Apr; 16(8):2235-45. PubMed ID: 20371684 [TBL] [Abstract][Full Text] [Related]
35. Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene. Frohnert BI; Hui TY; Bernlohr DA J Biol Chem; 1999 Feb; 274(7):3970-7. PubMed ID: 9933587 [TBL] [Abstract][Full Text] [Related]
36. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532 [TBL] [Abstract][Full Text] [Related]
37. Regulation of adiponectin receptor 1 in human hepatocytes by agonists of nuclear receptors. Neumeier M; Weigert J; Schäffler A; Weiss T; Kirchner S; Laberer S; Schölmerich J; Buechler C Biochem Biophys Res Commun; 2005 Sep; 334(3):924-9. PubMed ID: 16023994 [TBL] [Abstract][Full Text] [Related]